{"created":"2023-06-20T14:29:06.231092+00:00","id":5105,"links":{},"metadata":{"_buckets":{"deposit":"7f3c4393-a336-4600-971f-2d287bbf040f"},"_deposit":{"created_by":14,"id":"5105","owners":[14],"pid":{"revision_id":0,"type":"depid","value":"5105"},"status":"published"},"_oai":{"id":"oai:dmu.repo.nii.ac.jp:00005105","sets":["81:226"]},"author_link":["10744"],"item_10001_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2021-10-25","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"3","bibliographicPageEnd":"313","bibliographicPageStart":"303","bibliographicVolumeNumber":"48","bibliographic_titles":[{"bibliographic_title":"Dokkyo Journal of Medical Sciences"}]}]},"item_10001_description_34":{"attribute_name":"要旨","attribute_value_mlt":[{"subitem_description":"2019年末から始まった新型コロナウイルス感染症（COVID-19）は2年近く経過した今も世界中で公衆衛生上の問題となっており，COVID-19制圧には効果的なワクチンと治療薬の開発が喫緊の課題である．COVID-19の与えた国際社会へのインパクトは大きく，多くの研究者や企業がワクチンや治療薬の開発に尽力し，日本国内でもワクチンや抗体カクテル薬などが既に認可されている．特にワクチンにおいては従来のワクチン種別に無いmRNAワクチン2種とウイルスベクターワクチン1種が先んじて特例承認という形で日本でも認可されている．本稿では，これら日本国内で承認されたワクチンの詳細を中心に新型コロナウイルスに対するワクチン開発状況を解説する．また，日本国内での接種後副反応の出現状況やワクチン接種に係る懸念事項（ワクチンによる感染増強や変異株に対する有効性など）についても論じたい．","subitem_description_type":"Other"}]},"item_10001_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"獨協医学会"}]},"item_10001_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AA00629581","subitem_source_identifier_type":"NCID"}]},"item_10001_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"03855023","subitem_source_identifier_type":"ISSN"}]},"item_10001_text_24":{"attribute_name":"著者所属","attribute_value_mlt":[{"subitem_text_value":"獨協医科大学 微生物学"}]},"item_10001_text_29":{"attribute_name":"特集名(日)","attribute_value_mlt":[{"subitem_text_value":"新型コロナウイルス感染症2019"}]},"item_10001_text_30":{"attribute_name":"特集名(英)","attribute_value_mlt":[{"subitem_text_language":"en","subitem_text_value":"Coronavirus Disease 2019"}]},"item_10001_text_33":{"attribute_name":"記事種別","attribute_value_mlt":[{"subitem_text_value":"特集"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"石川, 知弘"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2022-02-10"}],"displaytype":"detail","filename":"DJMS-48-3-23.pdf","filesize":[{"value":"508.3 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"DJMS-48-3-石川-本文","url":"https://dmu.repo.nii.ac.jp/record/5105/files/DJMS-48-3-23.pdf"},"version_id":"10fcccdf-0fa0-478e-a20b-10f14bd929fa"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"新型コロナウイルス","subitem_subject_scheme":"Other"},{"subitem_subject":"ワクチン","subitem_subject_scheme":"Other"},{"subitem_subject":"mRNA","subitem_subject_scheme":"Other"},{"subitem_subject":"ウイルスベクター","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"新型コロナウイルスワクチン","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"新型コロナウイルスワクチン"},{"subitem_title":"Vaccines Against COVID-19","subitem_title_language":"en"}]},"item_type_id":"10001","owner":"14","path":["226"],"publish_date":"2022-02-10","publish_status":"0","recid":"5105","relation_version_is_last":true,"title":["新型コロナウイルスワクチン"],"weko_creator_id":"14","weko_shared_id":-1},"updated":"2023-06-20T14:45:44.807842+00:00"}